We’re not interested in what we already know, we’re interested in what’s novel.

Through the power of our platform: Recursion OS, we are able to identify undrugged targets. With one of the largest biological and chemical datasets coupled with the ability to rapidly layer on scientific literature using LLMs, we are now automatically initiating new discovery programs at scale.

See how we use a data driven approach to identify impactful and untapped drug targets using our Recursion OS.